NO751753L - - Google Patents

Info

Publication number
NO751753L
NO751753L NO751753A NO751753A NO751753L NO 751753 L NO751753 L NO 751753L NO 751753 A NO751753 A NO 751753A NO 751753 A NO751753 A NO 751753A NO 751753 L NO751753 L NO 751753L
Authority
NO
Norway
Prior art keywords
methylstyrene
propanol
butylphenyl
analysis
found
Prior art date
Application number
NO751753A
Other languages
Norwegian (no)
Inventor
W S Marshall
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO243371A external-priority patent/NO132724C/no
Publication of NO751753L publication Critical patent/NO751753L/no
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to NO751753A priority Critical patent/NO751753L/no

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

Foreliggende oppfinnelse angår fremgangsmåter for fremstilling av nye aralkylhydrokarboner med følgende formel: The present invention relates to methods for the production of new aralkyl hydrocarbons with the following formula:

hvor Ar representerer 3-fenoksyfenyl, 3-fenyltiofenyl, 4-fenyltiofenyl, 4-cykloheksylfenyl, 4-iso-butylfenyl, 4-cykloheksyl-3-klor-fenyl, 4-fenoksy-3-metylfenyl, 4-fenoksy-3-metoksyfenyl, 4'-fluorbifenyl, 3-klor-4-allyloksyfenyl, 4-n-butylfenyl eller 4-sec-butylfenyl,karakterisert vedat man dehydrolyserer en iso-propanolforbindelse med formelen Ar - C (CH^)20H'hvor Ar er som definert ovenfor. where Ar represents 3-phenoxyphenyl, 3-phenylthiophenyl, 4-phenylthiophenyl, 4-cyclohexylphenyl, 4-iso-butylphenyl, 4-cyclohexyl-3-chloro-phenyl, 4-phenoxy-3-methylphenyl, 4-phenoxy-3-methoxyphenyl , 4'-fluorobiphenyl, 3-chloro-4-allyloxyphenyl, 4-n-butylphenyl or 4-sec-butylphenyl, characterized by dehydrolysing an isopropanol compound with the formula Ar - C (CH^)20H', where Ar is as defined above.

Man får tilveiebrakt en symptomatisk lindring av in-flammasjon av følgende svelling, sårhet og ømhet samt nedsatt be-vegelighet, smerte og feber når man tilfører fra 1 til 100 mg/kg kropsvekt daglig av en aralkylforbindelse som definert ovenfor, Symptomatic relief of inflammation of the following swelling, soreness and tenderness as well as reduced mobility, pain and fever is provided when one adds from 1 to 100 mg/kg body weight daily of an aralkyl compound as defined above,

til mennesker og dyr som lider av inflammatoriske tilstander, og denne tilførsel kan enten skje oralt eller parentralt. to humans and animals suffering from inflammatory conditions, and this administration can be either oral or parenteral.

Blant forbindelser som kan.brukes i foreliggende oppfinnelse er følgende: Among compounds that can be used in the present invention are the following:

3- fenoksy-a-metylstyren 3-phenoxy-α-methylstyrene

4- sib-butyl-a-metylstyren 4-sib-butyl-a-methylstyrene

3- fenyltio-a-metylstyren 3-phenylthio-α-methylstyrene

4- fenyltio-a-metylstyren 4- phenylthio-α-methylstyrene

4-cykloheksyl -a-metylstyren 4-cyclohexyl-α-methylstyrene

3- metyl-4-fenoksy-a-metylstyren 3- methyl-4-phenoxy-α-methylstyrene

4- n-butyl-a-metylstyren 4-n-butyl-a-methylstyrene

4-sec-butyl-a-metylstyren 4-sec-butyl-α-methylstyrene

1-(4-kumenyl)cykloo-ten 1-(4-cumenyl)cycloethene

4-(4-fluorfenyl)-a-metylstyren 4-(4-fluorophenyl)-α-methylstyrene

3-metoksy-4-fenoksy-a-metylstyren 3-Methoxy-4-phenoxy-α-methylstyrene

3-klor-4-allyloksy-a-metylstyren 3-chloro-4-allyloxy-α-methylstyrene

De forbindelser som anvendes i praksis i forbindelse med foreliggende oppfinnelse er utmerkede anti-inflammatoriske midler og er vanligvis fri fra de sideeffekter som opptrer i tarmkanalen som man ofte ser i forbindelse med andre kjente midler. Eksempler på slik anti-inflammatorisk aktivitet er gitt i den etterfølgende tabell. Oral ED^q uttryktti mg/kg av forbindel-sene ifølge foreliggende oppfinnelse er bestemt ved en erytem-bokkerende prøve utført slik det i alt vesentlig er beskrevet av Winder, CV. et al.Archives Int.Pharmacodym, vol. 116, side 261 The compounds used in practice in connection with the present invention are excellent anti-inflammatory agents and are usually free of the side effects that occur in the intestinal tract that are often seen in connection with other known agents. Examples of such anti-inflammatory activity are given in the following table. Oral ED^q expressed as ten mg/kg of the compounds according to the present invention is determined by an erythema-inducing test carried out essentially as described by Winder, CV. et al. Archives Int. Pharmacodym, vol. 116, page 261

(1958). Resultatene er vist i den følgende tabell. (1958). The results are shown in the following table.

Generelt er det slik at forbindelser som anvendes i foreliggende oppfinnelse vil kunne la seg fremstillé ved fremgangsmåter som i seg selv er kjente for fremstilling av aralkylhydrokarboner. De anvendte forbindelser kan fremstilles fra en passende arylkarboksylsyre eller acetofenon. In general, it is the case that compounds used in the present invention can be prepared by methods which are known in themselves for the production of aralkyl hydrocarbons. The compounds used can be prepared from a suitable arylcarboxylic acid or acetophenone.

Et annet aspekt ifølge foreliggende oppfinnelse angår farmasøytiske preparater i doseenhet som er tilpasset en oral eller parenteral tilførsel. Man oppnår ved dette en anti-inflammatorisk effekt. En anti-inflammatorisk effektiv og ikke-toksisk mengde vil ligge i området fra ca. 50 til ca. 1000 milligram av en forbindelse med formelen Another aspect according to the present invention relates to pharmaceutical preparations in dosage units which are adapted for oral or parenteral administration. This results in an anti-inflammatory effect. An anti-inflammatory effective and non-toxic amount will be in the range from approx. 50 to approx. 1000 milligrams of a compound of the formula

som denne er definert ovenfor, samt et farmasøytisk fortynnings-middel. Et foretrukket farmasøytisk preparat er ett som er tilpasset oral tilførsel og som vil kunne være myke gelatinkapsler, harde gelatinkapsler eller tabletter slik disse er illustrert nedenfor. En foretrukken forbindelse for tilførsel ifølge dette aspekt er 4-fenylkumen, men man kan også bruke andre forbindelser av den type som er angitt ovenfor som en erstatning for alt eller deler av nevnte,4-fenylkumen. as defined above, as well as a pharmaceutical diluent. A preferred pharmaceutical preparation is one which is suitable for oral administration and which could be soft gelatin capsules, hard gelatin capsules or tablets as illustrated below. A preferred compound for delivery according to this aspect is 4-phenylcumene, but one can also use other compounds of the type indicated above as a substitute for all or part of said 4-phenylcumene.

Ovennevnte forbindelser kan som sagt fremstilles ved fremgangsmåter som i seg selv er kjente. De følgende eksempler illustrerer fremgangsmåter som kan brukes for fremstilling av forbindelser som kan brukes i foreliggende oppfinnelse. The above-mentioned compounds can, as said, be produced by methods which are known per se. The following examples illustrate methods that can be used for the preparation of compounds that can be used in the present invention.

Eksempel 1. Example 1.

Fremstilling av 2-( 4- bifenylyl)- 2- propanoi. Preparation of 2-(4-biphenylyl)-2-propane.

En oppløsning av 98 g 4-acetylbifenyl oppløst i 500 ml eter og 500 ml benzen, ble dråpevis under røring tilsatt 500 ml av en 2,15 molar oppløsning av metylmagnesiumklorid som var blitt fortynnet med tilsvarende volumeter, og med slik hastighet at reak-sjonen kokte svakt under tilbakeløp. Etter at tilsetningen var full-stendig, ble blandingen kokt under tilbakeløp over natten. A solution of 98 g of 4-acetylbiphenyl dissolved in 500 ml of ether and 500 ml of benzene was added dropwise with stirring to 500 ml of a 2.15 molar solution of methylmagnesium chloride which had been diluted with corresponding volumes, and at such a rate that the reaction boiled gently under reflux. After the addition was complete, the mixture was refluxed overnight.

Blandingen ble så avkjølt til romtemperatur og over-skudd av nevnte Grignard-reagens ble dekomponert ved dråpevis til-setning av 178 ml av en mettet ammoniumklorid-oppløsning. Det organiske lag ble avhelt fra det resulterende uorganiske residum og så helt over i isvann. Det organiske lag ble utskilt, vasket med fortynnet natriumbikarbonat-oppløsning og vann og så tørket over natriumsulfat. Fordampning av oppløsningsmidlene i vakuum ga et hvitt fast residum som ble utkrystallisert fra heksan, hvorved man fikk 85 g 2-(4-bifenylyl)-2-propanol, smeltepunkt 88,5 - 90,5°C. Analyse, beregnet for C.-H--0: C, 84,87; H, 7,60. The mixture was then cooled to room temperature and the excess of said Grignard reagent was decomposed by the dropwise addition of 178 ml of a saturated ammonium chloride solution. The organic layer was decanted from the resulting inorganic residue and poured into ice water. The organic layer was separated, washed with dilute sodium bicarbonate solution and water and then dried over sodium sulfate. Evaporation of the solvents in vacuum gave a white solid residue which was crystallized from hexane, whereby 85 g of 2-(4-biphenylyl)-2-propanol were obtained, melting point 88.5 - 90.5°C. Analysis, calculated for C.-H--O: C, 84.87; H, 7.60.

lb lb lb lb

Funnet:. C, 85,01; H, 7,54. Found: C, 85.01; H, 7.54.

Denne forbindelse kan brukes for å fremstille 4-fenyl-a-metylstyren ved den fremgangsmåte som er angitt i eksempel 10. Eksemplene 2- 9. This compound can be used to prepare 4-phenyl-a-methylstyrene by the method indicated in example 10. Examples 2-9.

De følgende forbindelser ble fremstilt som angitt i eksempel 1, fra det tilsvarende acetofenon eller substituert benzo- atester, ved å bruke passende mengder av metylmagnesiumhalid-oppløsning: 2-(3-fenyltiofenyl)-2-propanol, kokepunkt, 154-156°/0,05 ram; The following compounds were prepared as indicated in Example 1, from the corresponding acetophenone or substituted benzoate ester, using appropriate amounts of methylmagnesium halide solution: 2-(3-phenylthiophenyl)-2-propanol, b.p. 154-156°/ 0.05 ram;

23 23

nD = 1,6132, fra 3-fenyltioacetofenon. nD = 1.6132, from 3-phenylthioacetophenone.

Analyse, beregnet for C15H160S; C, 73,72; H, 6,60; S, 13,12. Analysis, calculated for C15H160S; C, 73.72; H, 6.60; S, 13,12.

Funnet: C, 73,46; H, 6,63; S, 13,35. Found: C, 73.46; H, 6.63; S, 13.35.

2-(4-fenyltiofenyl)-2-propanol, kokepunkt, 144-153°C/0,09 mm; 2-(4-phenylthiophenyl)-2-propanol, bp, 144-153°C/0.09 mm;

25 25

nD =1,6154, fra 4-fenyltioacetofenon. nD =1.6154, from 4-phenylthioacetophenone.

Analyse, beregnet for C^H^OS: C, 73,72; H, 6,60; S, 13,12. Analysis, calcd for C 2 H 2 O 2 : C, 73.72; H, 6.60; S, 13,12.

Funnet: C, 73,99; H, 6,89! S, 12,91. 2-(4-iso-butylfenyl)-2-propanol, kokepunkt, 77-85°/0,16 mm; Found: C, 73.99; H, 6.89! S, 12.91. 2-(4-iso-butylphenyl)-2-propanol, bp, 77-85°/0.16 mm;

25 25

nD = 1,5050, fra 4-iso-butylacetofenon. nD = 1.5050, from 4-iso-butylacetophenone.

Analyse, beregnet for C13H20<0:>C, 81,20; H, 10,48 Analysis, calculated for C13H20<0:>C, 81.20; H, 10.48

Funnet: C, 80,97; H, 1052. Found: C, 80.97; H, 1052.

2-(4-sec-butylfenyl)-2-propanol, kokepunkt 73-80°/0,05 mm, 2-(4-sec-butylphenyl)-2-propanol, boiling point 73-80°/0.05 mm,

nD<23>=1,5094, fra 4-sec-butylacetofenon. nD<23>=1.5094, from 4-sec-butylacetophenone.

Analyse, beregnet for C13H2()0: C, 81,20; H,, 1048. Analysis, calcd for C13H2()0: C, 81.20; H,, 1048.

Funnet: C, 81,09; H, 10,71. 2-(4-cykloheksylfenyl)-2-propanol, smeltepunkt: 71-74 C, Found: C, 81.09; H, 10.71. 2-(4-cyclohexylphenyl)-2-propanol, melting point: 71-74 C,

fra 4-cykloheksylacetofenon. from 4-cyclohexylacetophenone.

Analyse, beregnet for C^H^O: C, 82,51; H, 10,16. Analysis, calcd for C 2 H 2 O: C, 82.51; H, 10,16.

Funnet: C, 82,49; H, 10,04. 2-(3-metoksy-4-fenoksyfenyl)-2-propanol, kokepunkt, 170-177 /0,07mmnD<25>=1,5762 fra 3-metoksy-4-fenoksy-acetofenon. Found: C, 82.49; H, 10.04. 2-(3-Methoxy-4-phenoxyphenyl)-2-propanol, bp, 170-177 /0.07mmnD<25>=1.5762 from 3-methoxy-4-phenoxy-acetophenone.

Analyse, beregnet for C16Hlg03: C,<74,39>; H, 7,02. Analysis, calculated for C 16 HlgO 3 : C,<74.39>; H, 7.02.

Funnet: C, 74,58; H, 7,29. 2-(3-met£5lL-4-fenoksyfenyl)-2-propanol, kokepunkt, 145-146°/0, 08 mm, n d 25=1,5705, fra 3-metyl-4-fenoksy-acetofenon. 2-(4'-fluorbifenylyl)-2-propanol, smeltepunkt, 110-111 , fra 4'-fluor-4-acetylbifenyl. Found: C, 74.58; H, 7.29. 2-(3-Methyl-4-phenoxyphenyl)-2-propanol, bp, 145-146°/0.08 mm, n d 25=1.5705, from 3-methyl-4-phenoxy-acetophenone. 2-(4'-fluorobiphenylyl)-2-propanol, m.p., 110-111 , from 4'-fluoro-4-acetylbiphenyl.

Analyse, beregnet for C15H15<F>O: C 78,24; H, 6,57 Analysis, calculated for C15H15<F>O: C 78.24; H, 6.57

Funnet: C,77,95; H, 6,79. Found: C, 77.95; H, 6.79.

Disse alkoholer ble omdannet til a-metylstyrener ved den fremgangsmåte som er angitt i eksempel 10. These alcohols were converted into α-methylstyrenes by the method indicated in example 10.

Eksempel 10. Example 10.

Fremstilling av 4- fenyl- a- metylstyren. Production of 4-phenyl-a-methylstyrene.

En suspensjon av 42,4 g 2-(4-bifenylyl)-2-propanol i 100 ml 4N svovelsyre og 50 ml etanol ble kokt under tilbakeløp og kraftig røring i 1.1/2 time. Deretter ble 50 ml etanol tilsatt, og blandingen ble kokt under tilbakeløp i ytterligere 2.1/2 time. Etter avkjøling til romtemperatur ble blandingen helt over i isvann og ekstrahert med eter, benzen og kloroform. De organiske ekstrakter ble slått sammen, og vasket med natriumbikarbonatoppløsning og vann, og så tørket over natriumsulfat. Etter fordampning av oppløsningsmidlene i vakuum ble residumet utkrystallisert fra heksan, hvorved man fikk 23,4 g 4-fenyl-a-metylstyren, smeltepunkt 116-118°C. A suspension of 42.4 g of 2-(4-biphenylyl)-2-propanol in 100 ml of 4N sulfuric acid and 50 ml of ethanol was boiled under reflux and vigorous stirring for 1.1/2 hours. Then 50 ml of ethanol was added and the mixture was refluxed for a further 2.1/2 hours. After cooling to room temperature, the mixture was poured into ice water and extracted with ether, benzene and chloroform. The organic extracts were combined, and washed with sodium bicarbonate solution and water, and then dried over sodium sulfate. After evaporation of the solvents in vacuo, the residue was crystallized from hexane, whereby 23.4 g of 4-phenyl-a-methylstyrene was obtained, melting point 116-118°C.

Analyse, beregnet for C. _H, .: C, 92,74: H, 7,26 Analysis, calculated for C. _H, .: C, 92.74: H, 7.26

lb 14 lb 14

Funnet: C, 92,45; H, 6,98. Found: C, 92.45; H, 6.98.

Eksempel 11- 21. Example 11-21.

De følgende forbindelser ble fremstilt som angitt i eksempel 10 ved å bruke en passende propanol som utgangsmateriale. 3-fenyltio-a-metylstyren, kokepunkt 113-115°/0,05 mm; = The following compounds were prepared as indicated in Example 10 using an appropriate propanol as starting material. 3-phenylthio-a-methylstyrene, boiling point 113-115°/0.05 mm; =

1,6248 som inneholder 10% av utgangskarbinolen, slik denne kunne måles ved Nmr, fra 2-(3-fenyltio-fenyl)-2-propanol. 1.6248 which contains 10% of the starting carbinol, as this could be measured by Nmr, from 2-(3-phenylthio-phenyl)-2-propanol.

4-fenyltio-ot-metylstyren, kokepunkt 147-167/0,2 mm; n^ 25 = 1,6374, fra 2-(4-fenyltiofenyl)-2-propanol. 4-phenylthio-o-methylstyrene, boiling point 147-167/0.2 mm; n^ 25 = 1.6374, from 2-(4-phenylthiophenyl)-2-propanol.

Analyse, beregnet for C, cH1ylS: C, 79,62;H,6,24. Analysis, calculated for C, cH1ylS: C, 79.62; H, 6.24.

lo 14 laughed 14

Funnet: C, 79,49; H,. 6,64. Found: C, 79.49; H,. 6.64.

4-iso-butyl-a-metylstyren, kokepunkt, 75-100°/0,4 mm; nD 25 = 1,5182, fra 2-(4-iso-butylfenyl)-2-propanol. 4-iso-butyl-a-methylstyrene, boiling point, 75-100°/0.4 mm; nD 25 = 1.5182, from 2-(4-iso-butylphenyl)-2-propanol.

Analyse, beregnet for C^H.^: C, 89,59; H, 10,41 Analysis, calcd for C 2 H 2 : C, 89.59; H, 10.41

Funnet: C, 89,52; H, 10,49 Found: C, 89.52; H, 10.49

4-sec-butyl-a-metylstyren, kokepunkt, 52-53°/0,07 mm; nD<24>= 1,5188, fra 2-(4-sec-butylfenyl)-2-propanol. 4-sec-butyl-α-methylstyrene, bp, 52-53°/0.07 mm; nD<24>= 1.5188, from 2-(4-sec-butylphenyl)-2-propanol.

Analyse, beregnet for C13Hlg: C, 89,59; H, 10,41. Analysis, calcd for C13Hlg: C, 89.59; H, 10.41.

Funnet: C, 89,36; H, 10,43. Found: C, 89.36; H, 10.43.

4-cykloheksyl-a-metylstyren, kokepunkt 122-14 2°/ 4-cyclohexyl-α-methylstyrene, boiling point 122-14 2°/

25 25

0,15 mm; nD = 1,5484, fra 2-(4-cykloheksylfenyl)-2-propanol. Analyse, beregnet for C.,-H0rt: C, 89,94; H, 10,06. 0.15mm; nD = 1.5484, from 2-(4-cyclohexylphenyl)-2-propanol. Analysis, calculated for C.,-H0rt: C, 89.94; H, 10.06.

lo 2U laughed 2U

Funnet: C, 90,15; H, 10,33. Found: C, 90.15; H, 10.33.

3-metyl-4-fenoksy-a-metylstyren,- kokepunkt 125-134°/0,08 mm, nD<25>= 1,5856, fra 2-(3-metyl-4-fenoksyfenyl)-2-propanol. 3-methyl-4-phenoxy-α-methylstyrene, bp 125-134°/0.08 mm, nD<25>= 1.5856, from 2-(3-methyl-4-phenoxyphenyl)-2-propanol.

Analyse, beregnet for C,, E., 0: C, 85,68; H, 7,19. Analysis, calculated for C,, E., 0: C, 85.68; H, 7.19.

lb lb lb lb

Funnet: C, 85,44; H, 7,06 Found: C, 85.44; H, 7.06

3-metoksy-4-fenoksy-a-metylstyren, kokepunkt 157-160°/0,07 mm; nD<25>= 1,5914, fra 2-(3-metoksy-4-fenoksyfenyl)-2-propanol. 3-methoxy-4-phenoxy-α-methylstyrene, boiling point 157-160°/0.07 mm; nD<25>= 1.5914, from 2-(3-methoxy-4-phenoxyphenyl)-2-propanol.

Analyse, beregnet for C.,H1C0_: C, 79,97; H, 6,71 Analysis, calcd for C.,H 1 CO_: C, 79.97; H, 6.71

lb lbZlb lbZ

Funnet: C, 79,75; H, 6,76. . 4-(4-fluorfenyl)-a-metylstyren, smeltepunkt, 127-128°, fra 2- (4 ' -fluorbifenylyl) -^2-propanol. Found: C, 79.75; H, 6.76. . 4-(4-fluorophenyl)-α-methylstyrene, m.p., 127-128°, from 2-(4'-fluorobiphenylyl)-^2-propanol.

Analyse, beregnet for C, 84,87; H, 6,17. Analysis, calculated for C, 84.87; H, 6.17.

Funnet: C, 84,68; H, 6,45. Found: C, 84.68; H, 6.45.

3-fenoksy-ct-metylstyren, kokepunkt, 103-115°/0,08 mm; 3-phenoxy-ct-methylstyrene, bp, 103-115°/0.08 mm;

25 25

nD = 1,5873, fra 2-(3-fenoksyfenyl)-2-propanol. nD = 1.5873, from 2-(3-phenoxyphenyl)-2-propanol.

Analyse, beregnet for ci5Hi4°» c'85,68; H, .6,71. Analysis, calculated for 15H14°» c'85.68; H, .6.71.

Funnet: C, 85,69; H, 6,90. 3- klor-4-allyloksy-a-metylstyren, kokepunkt, 99-105°/0,07 mm; nD<24>= 1,5623, fra 2-(3-klor-4-allyloksyfenyl)-2-propanol. Found: C, 85.69; H, 6.90. 3-chloro-4-allyloxy-a-methylstyrene, bp, 99-105°/0.07 mm; nD<24>= 1.5623, from 2-(3-chloro-4-allyloxyphenyl)-2-propanol.

Analyse, beregnet for c12Hi3Cio: C'69'14'H' 6'29*' P» 7,68. . Funnet: C, 69,23: H, 6,20; 0, 7,85* 4- n-butyl-a-metylstyren, kokepunkt, 84-88°/0,05 mm; nD 21= 1,5182, fra 2-(4-n-butylfenyl)-2-propanol. Analysis, calculated for c12Hi3C10: C'69'14'H' 6'29*' P» 7.68. . Found: C, 69.23: H, 6.20; 0, 7.85* 4- n-butyl-a-methylstyrene, bp, 84-88°/0.05 mm; nD 21 = 1.5182, from 2-(4-n-butylphenyl)-2-propanol.

Analyse, beregnet for C--.H10: e, 89,48; H, 10,48. Analysis, calcd for C--.H10: e, 89.48; H, 10.48.

1 j lo 1 j lo

Claims (3)

1. Fremgangsmåte for fremstilling av nye aralkylhydrokarboner med formelen: 1. Process for the production of new aralkyl hydrocarbons with the formula: hvor Ar representerer 3-fenoksyfenyl, 3-fenyltiofenyl, 4-fenyltiofenyl, 4-cykloheksylfenyl, 4-iso-butylfenyl, 4-cykloheksyl-3-klorfenyl, 4-fenoksy-3-metylfenyl, 4-fenoksy-3-metoksy-fenyl, 4<1->fluorbifenyl, 3-klor-4-allyloksyfenyl, 4-n-butylfenyl eller 4-sec-butylfenyl,karakterisert vedat man dehydrolyserer en iso-propanolforbindelse med formelen Ar - C ( CE^) ^ OB. hvor Ar er som definert ovenfor.where Ar represents 3-phenoxyphenyl, 3-phenylthiophenyl, 4-phenylthiophenyl, 4-cyclohexylphenyl, 4-iso-butylphenyl, 4-cyclohexyl-3-chlorophenyl, 4-phenoxy-3-methylphenyl, 4-phenoxy-3-methoxy-phenyl , 4<1->fluorobiphenyl, 3-chloro-4-allyloxyphenyl, 4-n-butylphenyl or 4-sec-butylphenyl, characterized by dehydrolyzing an iso-propanol compound with the formula Ar - C ( CE^) ^ OB. where Ar is as defined above. 2. Fremgangsmåte ifølge krav 1,karakterisert vedat Ar er 3-fenyltiofenyl, 3-klor-4-allyloksy-fenyl, 4-n-butylfenyl eller 4-sec-butylfenyl ogR<1>er iso-propenyl.2. Method according to claim 1, characterized in that Ar is 3-phenylthiophenyl, 3-chloro-4-allyloxy-phenyl, 4-n-butylphenyl or 4-sec-butylphenyl and R<1> is iso-propenyl. 3. Fremgangsmåte ifølge krav 1,karakterisert vedat Ar er 4-fenoksy-3-metoksyfenyl eller 4.<1->fluorbifenyl.3. Method according to claim 1, characterized in that Ar is 4-phenoxy-3-methoxyphenyl or 4.<1->fluorobiphenyl.
NO751753A 1970-11-20 1975-05-16 NO751753L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO751753A NO751753L (en) 1970-11-20 1975-05-16

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9155970A 1970-11-20 1970-11-20
US12923771A 1971-03-29 1971-03-29
NO243371A NO132724C (en) 1970-11-20 1971-06-25
NO751753A NO751753L (en) 1970-11-20 1975-05-16

Publications (1)

Publication Number Publication Date
NO751753L true NO751753L (en) 1972-05-24

Family

ID=27484001

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751753A NO751753L (en) 1970-11-20 1975-05-16

Country Status (1)

Country Link
NO (1) NO751753L (en)

Similar Documents

Publication Publication Date Title
US4230862A (en) Antifertility compounds
US3576883A (en) Alkylidenedithiobisphenols
PT84860B (en) METHOD FOR PREPARING NEW TETRAHYDROFOLANTALEN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DD145101A5 (en) PROCESS FOR THE PREPARATION OF INDA YL DERIVATIVES
CA1093087A (en) Retinoic acid derivatives
CA1245663A (en) 1-nitrogen containing-7-hydroxy-indone derivatives and salts thereof
US2771391A (en) Physiologically active p-alkoxy-beta-piperidinopropiophenones causing cns depressantand anesthetic effects in animals
US3427305A (en) 5 - ((halo/alkoxy)phenyl) - 1 - (p - sulfonamido(phenyl/benzyl)) - 2 - pyrrolepropionic acids
NO164348B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALKENE COMPOUNDS.
US3991212A (en) Anti-inflammatory agents
US4590205A (en) Antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
NO751753L (en)
EP0010361A1 (en) Bis-imidazoles, their preparation and pharmaceutical compositions containing them
EP0087629A2 (en) Antiinflammatory and/or analgesic 2,3-Diaryl-5-halo thiophenes
US2789138A (en) d-nu-methyl-nu-benzyl-beta-phenyliso-propylamine
US4029803A (en) Method of treatment with 2-iminothiazolidines and thiazolines
US4096250A (en) Tri-substituted phosphinegold(I) 1-thio-β-D-glucopyranosides
US4008327A (en) Tolyloxypivalophenone derivatives
US4065503A (en) P-Phenoxy-alkylphenones and corresponding alcohols
US4122191A (en) Antirhinovirus agents
US3979468A (en) 4&#39;-Chloro-4-ethynylbiphenyl and method of preparing same
US3494964A (en) Alpha-halo-alpha-amino ketones
US4171360A (en) Phosphinegold (I) salts having antiarthritic activity
JPS6114141B2 (en)
US3151148A (en) Cyano stilbene hypocholesterolemic